Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Enanta Pharmaceutica (ENTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,994,165
  • Shares Outstanding, K 19,442
  • Annual Sales, $ 206,630 K
  • Annual Income, $ 71,960 K
  • 60-Month Beta 1.39
  • Price/Sales 9.53
  • Price/Cash Flow 26.64
  • Price/Book 4.61

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.07
  • Number of Estimates 4
  • High Estimate 0.20
  • Low Estimate -0.30
  • Prior Year 0.61
  • Growth Rate Est. (year over year) -111.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
95.21 +7.83%
on 03/08/19
106.80 -3.87%
on 03/04/19
+1.44 (+1.43%)
since 02/19/19
3-Month
64.08 +60.20%
on 12/24/18
106.80 -3.87%
on 03/04/19
+32.26 (+45.83%)
since 12/19/18
52-Week
64.08 +60.20%
on 12/24/18
127.77 -19.65%
on 07/06/18
+16.11 (+18.61%)
since 03/19/18

Most Recent Stories

More News
Enanta Pharmaceuticals Completes Enrollment in Two Ongoing Phase 2 Studies

--ARGON-1 Study in Non-alcoholic Steatohepatitis (NASH) with EDP-305

ENTA : 102.67 (+0.09%)
Enanta Pharmaceu Rises 1.43% on Heavy Volume: Watch For Potential Pullback

Enanta Pharmaceu (NASDAQ:ENTA) traded in a range yesterday that spanned from a low of $103.21 to a high of $103.54. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high...

ENTA : 102.67 (+0.09%)
Enanta Pharmaceu Up 36.6% Since SmarTrend Uptrend Call (ENTA)

SmarTrend identified an Uptrend for Enanta Pharmaceu (NASDAQ:ENTA) on January 7th, 2019 at $74.33. In approximately 2 months, Enanta Pharmaceu has returned 36.55% as of today's recent price of $101.50....

ENTA : 102.67 (+0.09%)
Uptrend Call Working As Enanta Pharmaceu Stock Rises 37.4% (ENTA)

SmarTrend identified an Uptrend for Enanta Pharmaceu (NASDAQ:ENTA) on January 7th, 2019 at $74.33. In approximately 2 months, Enanta Pharmaceu has returned 37.41% as of today's recent price of $102.14....

ENTA : 102.67 (+0.09%)
AbbVie reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for its hepatitis C treatment MAVIRET(TM)

AbbVie (NYSE: ABBV), a global, research and development-based biopharmaceutical company, announced an agreement was reached with the pan-Canadian Pharmaceutical Alliance (pCPA) regarding MAVIRETTM (glecaprevir/pibrentasvir...

ENTA : 102.67 (+0.09%)
ABBV : 80.76 (+0.14%)
36.0% Return Seen to Date on SmarTrend Enanta Pharmaceu Call (ENTA)

SmarTrend identified an Uptrend for Enanta Pharmaceu (NASDAQ:ENTA) on January 7th, 2019 at $74.33. In approximately 1 month, Enanta Pharmaceu has returned 36.00% as of today's recent price of $101.09....

ENTA : 102.67 (+0.09%)
Factors of Influence in 2019, Key Indicators and Opportunity within BCE, Nektar Therapeutics, Hormel Foods, Enanta Pharmaceuticals, MongoDB, and Regal Beloit -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of BCE, Inc. (NYSE:BCE), Nektar...

RBC : 83.09 (+0.47%)
HRL : 42.57 (+0.05%)
BCE : 44.35 (-0.07%)
ENTA : 102.67 (+0.09%)
MDB : 137.70 (-0.20%)
NKTR : 34.49 (-1.26%)
Noteworthy Wednesday Option Activity: ENTA, INSM, PPC

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Enanta Pharmaceuticals Inc , where a total volume of 1,646 contracts has been traded...

ENTA : 102.67 (+0.09%)
Enanta Pharmaceu Shares Up 20.9% Since SmarTrend's Buy Recommendation (ENTA)

SmarTrend identified an Uptrend for Enanta Pharmaceu (NASDAQ:ENTA) on January 7th, 2019 at $74.33. In approximately 1 month, Enanta Pharmaceu has returned 20.93% as of today's recent price of $89.89.

ENTA : 102.67 (+0.09%)
Enanta Pharmaceuticals (ENTA) Lags Q1 Earnings and Revenue Estimates

Enanta Pharmaceuticals (ENTA) delivered earnings and revenue surprises of -14.38% and -4.34%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?...

ENTA : 102.67 (+0.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade ENTA with:

Business Summary

Enanta Pharmaceuticals, Inc. is a biotechnology company. It engages in the research and development of molecule drugs for the treatment of infectious diseases such as hepatitis C virus, respiratory tract infections, intravenous and oral treatments. Enanta Pharmaceuticals, Inc. is headquartered in Watertown,...

See More

Key Turning Points

2nd Resistance Point 107.43
1st Resistance Point 105.00
Last Price 102.67
1st Support Level 100.59
2nd Support Level 98.61

See More

52-Week High 127.77
Fibonacci 61.8% 103.44
Last Price 102.67
Fibonacci 50% 95.93
Fibonacci 38.2% 88.41
52-Week Low 64.08

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar